Current reviews depicting therapeutic potential of novel drug delivery system in rheumatoid arthritis

Open Access

Issue		BIO Web Conf. Volume 86, 2024 International Conference on Recent Trends in Biomedical Sciences (RTBS-2023)


Article Number		01035
Number of page(s)		16
DOI		https://doi.org/10.1051/bioconf/20248601035
Published online		12 January 2024

Bullock, J., Rizvi, S. A. A., Saleh, A. M., Ahmed, S., Do, D. P., Ansari, R. A., & Ahmed, J. (n.d.). Rheumatoid Arthritis: A Brief Overview of the Treatment. [Google Scholar]
Kesharwani, D., Paliwal, R., Satapathy, T., & Paul, S. das. (2019). Rheumatiod arthritis: An updated overview of latest therapy and drug delivery. Journal of Pharmacopuncture, 22(4), 210–224. https://doi.org/10.3831/KPI.2019.22.029 [CrossRef] [PubMed] [Google Scholar]
Mcinnes, I. B., & Schett, G. (n.d.). The Pathogenesis of Rheumatoid Arthritis. [Google Scholar]
Zhang, M., Hu, W., Cai, C., Wu, Y., Li, J., & Dong, S. (2022). Advanced application of stimuli-responsive drug delivery system for inflammatory arthritis treatment. In Materials Today Bio (Vol. 14). Elsevier B.V. https://doi.org/10.1016/j.mtbio.2022.100223 [Google Scholar]
Thakur, S., Riyaz, B., Patil, A., Kaur, A., Kapoor, B., & Mishra, V. (2018). Novel drug delivery systems for NSAIDs in management of rheumatoid arthritis: An overview. In Biomedicine and Pharmacotherapy (Vol. 106, pp. 1011–1023). Elsevier Masson SAS. https://doi.org/10.1016/j.biopha.2018.07.027 [CrossRef] [Google Scholar]
Montecucco, F., & Mach, F. (2009). Common inflammatory mediators orchestrate pathophysiological processes in rheumatoid arthritis and atherosclerosis. In Rheumatology (Vol. 48, Issue 1, pp. 11–22).https://doi.org/10.1093/rheumatology/ken395 [Google Scholar]
Deane, K. D., Norris, J. M., & Holers, V. M. (2010). Preclinical rheumatoid arthritis: Identification, evaluation, and future directions for investigation. In Rheumatic Disease Clinics of North America (Vol. 36, Issue 2, pp. 213–241).https://doi.org/10.1016/j.rdc.2010.02.001 [CrossRef] [Google Scholar]
Deane, K. D., & El-Gabalawy, H. (2014a). Pathogenesis and prevention of rheumatic disease: Focus on preclinical RA and SLE. In Nature Reviews Rheumatology (Vol. 10, Issue 4, pp. 212–228). Nature Publishing Group.https://doi.org/10.1038/nrrheum.2014.6 [CrossRef] [PubMed] [Google Scholar]
Aletaha, D., Neogi, T., Silman, A. J., Funovits, J., Felson, D. T., Bingham, C. O., Birnbaum, N. S., Burmester, G. R., Bykerk, V. P., Cohen, M. D., Combe, B., Costenbader, K. H., Dougados, M., Emery, P., Ferraccioli, G., Hazes, J. M. W., Hobbs, K., Huizinga, T. W. J., Kavanaugh, A., … Hawker, G. (2010). 2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative. In Arthritis and Rheumatism (Vol. 62, Issue 9, pp. 2569–2581). John Wiley and Sons Inc. https://doi.org/10.1002/art.27584 [CrossRef] [PubMed] [Google Scholar]
Bonanomi, M. H., Velvart, M., Stimpel, M., Roos, K. M., Fehr, K., & Weder, H. G. (1987). Studies of pharmacokinetics and therapeutic effects Rheuin !ogy Clinical end Experimental Investigations of glucocorticoids entrapped in liposomes after intraarticular application in healthy rabbits and in rabbits with antigen-induced arthritis. In Rheumatol Int (Vol. 7). [Google Scholar]
Dolati, S., Sadreddini, S., Rostamzadeh, D., Ahmadi, M., Jadidi-Niaragh, F., & Yousefi, M. (2016). Utilization of nanoparticle technology in rheumatoid arthritis treatment. In Biomedicine and Pharmacotherapy (Vol. 80, pp. 30–41). Elsevier Masson SAS.https://doi.org/10.1016/j.biopha.2016.03.004 [CrossRef] [Google Scholar]
Edwards, C. J., & Cooper, C. (2006). Early environmental factors and rheumatoid arthritis. In Clinical and Experimental Immunology (Vol. 143, Issue 1, pp. 1–5).https://doi.org/10.1111/j.1365-2249.2005.02940.x [CrossRef] [Google Scholar]
Liao, K. P., Alfredsson, L., & Karlson, E. W. (2009a). Environmental influences on risk for rheumatoid arthritis. In Current Opinion in Rheumatology (Vol. 21, Issue 3, pp. 279–283).https://doi.org/10.1097/BOR.0b013e32832a2e16 [CrossRef] [PubMed] [Google Scholar]
Emery, P. (n.d.). Clinical review Treatment of rheumatoid arthritis. [Google Scholar]
Holder, A. A. (2011). Inorganic pharmaceuticals. In Annual Reports on the Progress of Chemistry - Section A (Vol. 107, pp. 359–378).https://doi.org/10.1039/c1ic90005f [CrossRef] [Google Scholar]
Choy, E. H. (n.d.). Choy New prospects for the treatment of rheumatoid arthritis New prospects for the treatment of rheumatoid arthritis. http://www.ashley-pub.com [Google Scholar]
Laine, L. (2001). Approaches to nonsteroidal anti-inflammatory drug use in the high-risk patient. Gastroenterology, 120(3), 594–606.https://doi.org/10.1053/gast.2001.21907 [CrossRef] [PubMed] [Google Scholar]
Guzmán, A., Díaz, E., Trejo, B. E., López-Muñoz, F. J., & Cruz Almanza, R. (2004). Synthesis of Potential Anti- inflammatory Compounds, Selective Inhibitors of Cyclooxygenase-2 (COX-2). In Rev. Soc. Quím. Méx (Vol. 48). [Google Scholar]
Adverse Effects of Nonsteroidal Anti-inflammatory Drugs on Renal Function. (1990).https://annals.org/ [Google Scholar]
J S Langman FRCP, U. M., Weil MRCP, J., Wainwright, P., Royal Infirmary, G., Murphy MFPHM, M., Vessey FRS, M. P., Alexandra Hospital, Q., Correspondence to, U., & S Langman, M. J. (n.d.). Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs. [Google Scholar]
Mohanty, S., Panda, S., Bhanja, A., Pal, A., & Chandra Si. (2019a). Novel drug delivery systems for rheumatoid arthritis: An approach to better patient compliance. Biomedical and Pharmacology Journal, 12(1), 157–170.https://doi.org/10.13005/bpj/1624 [CrossRef] [Google Scholar]
Coutinho, A. E., & Chapman, K. E. (2011). The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights. In Molecular and Cellular Endocrinology (Vol. 335, Issue 1, pp. 2–13).https://doi.org/10.1016/j.mce.2010.04.005 [CrossRef] [PubMed] [Google Scholar]
Kalso, E., Edwards, J. E., Moore, R. A., & McQuay, H. J. (2004). Opioids in chronic non-cancer pain: Systematic review of efficacy and safety. Pain, 112(3), 372–380.https://doi.org/10.1016/j.pain.2004.09.019 [CrossRef] [PubMed] [Google Scholar]
Frenk, S. M., Porter, K. S., & Paulozzi, L. J. (1999). Prescription Opioid Analgesic Use Among Adults: United States, 1999-2012 Key findings Data from the National Health and Nutrition Examination Survey.http://www.cdc.gov/nchs/data/databriefs/db189_table.pdf#3. [Google Scholar]
Malemud, C. J. (2009). The discovery of novel experimental therapies for inflammatory arthritis. In Mediators of Inflammation (Vol. 2009).https://doi.org/10.1155/2009/698769 [Google Scholar]
Emery, P., Keystone, E., Tony, H. P., Cantagrel, A., van Vollenhoven, R., Sanchez, A., Alecock, E., Lee, J., & Kremer, J. (2008). IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: Results from a 24-week multicentrerandomised placebo-controlled trial. Annals of the Rheumatic Diseases, 67(11), 1516–1523.https://doi.org/10.1136/ard.2008.092932 [CrossRef] [PubMed] [Google Scholar]
Rangasamy, M. (2010). Recent advances in novel drug delivery systems Multiparticulate drug delivery systems: Pellet and pelletization technique View project. In Article in International Journal of Research in Ayurveda and Pharmacy.http://www.ijrap.net [Google Scholar]
P.K. Singh, B. Gorain, H. Choudhury, S.K. Singh, P. Whadwa, S. Sahu, M. Gulati, P. Kesharwani, “Macrophage targeted amphotericin B nanodelivery systems against visceral leishmaniasis,” Materials Science and Engineering: B, vol. 258, p. 114571, 2020.https://doi.org/10.1016/j.mseb.2020.114571 [CrossRef] [Google Scholar]
Kaur, A., Goindi, S., & Katare, O. P. (2016). Formulation, characterisation and in vivo evaluation of lipid-based nanocarrier for topical delivery of diflunisal. Journal of Microencapsulation, 33(5), 475–486.https://doi.org/10.1080/02652048.2016.1216189 [CrossRef] [PubMed] [Google Scholar]
Amodwala, S., Kumar, P., & Thakkar, H. P. (2017a). Statistically optimized fast dissolving microneedle transdermal patch of meloxicam: A patient friendly approach to manage arthritis. European Journal of Pharmaceutical Sciences, 104, 114–123.https://doi.org/10.1016/j.ejps.2017.04.001 [CrossRef] [PubMed] [Google Scholar]
Chandrasekar, D., Sistla, R., Ahmad, F. J., Khar, R. K., & Diwan, P. v. (2007a). Folate coupled poly(ethyleneglycol) conjugates of anionic poly(amidoamine) dendrimer for inflammatory tissue specific drug delivery. Journal of Biomedical Materials Research - Part A, 82(1), 92–103.https://doi.org/10.1002/jbm.a.31122 [CrossRef] [Google Scholar]
Nagai, N., Yoshioka, C., & Ito, Y. (2015b). Topical therapies for rheumatoid arthritis by gel ointments containing indomethacin nanoparticles in adjuvant-induced arthritis rat. Journal of Oleo Science, 64(3), 337–346.https://doi.org/10.5650/jos.ess14170 [CrossRef] [PubMed] [Google Scholar]
Türker, S., Erdoǧan, S., Özer, Y., Bilgili, H., & Deveci, S. (2008a). Enhanced efficacy of diclofenac sodium-loaded lipogelosome formulation in intra-articular treatment of rheumatoid arthritis. Journal of Drug Targeting, 16(1), 51–57.https://doi.org/10.1080/10611860701725191 [CrossRef] [PubMed] [Google Scholar]
Goindi, S., Narula, M., & Kalra, A. (2016a). Microemulsion-Based Topical Hydrogels of Tenoxicam for Treatment of Arthritis. AAPS PharmSciTech, 17(3), 597–606.https://doi.org/10.1208/s12249-015-0383-0 [CrossRef] [PubMed] [Google Scholar]
Harinkhede, N. B., Avari, J. G., & Mahakal, N. S. (2015). FORMULATION AND EVALUATION OF POLYHERBAL EMULGEL FOR RHEUMATOID ARTHRITIS. Certified Journal │ Harinkhede et al. World Journal of Pharmaceutical Research 1074 World Journal of Pharmaceutical Research SJIF Impact Factor, 11, 1075.https://doi.org/10.20959/wjpr20224-23464 [Google Scholar]
Qi, X., Qin, X., Yang, R., Qin, J., Li, W., Luan, K., Wu, Z., & Song, L. (2016a). Intra-articular Administration of Chitosan Thermosensitive in Situ Hydrogels Combined with Diclofenac Sodium-Loaded Alginate Microspheres. Journal of Pharmaceutical Sciences, 105(1), 122–130.https://doi.org/10.1016/j.xphs.2015.11.019 [CrossRef] [PubMed] [Google Scholar]
Zhang, J. X., Yan, M. Q., Li, X. H., Qiu, L. Y., Li, X. D., Li, X. J., Jin, Y., & Zhu, K. J. (2007a). Local delivery of indomethacin to arthritis-bearing rats through polymeric micelles based on amphiphilic polyphosphazenes. Pharmaceutical Research, 24(10), 1944–1953.https://doi.org/10.1007/s11095-007-9322-4 [CrossRef] [PubMed] [Google Scholar]
IEEE Engineering in Medicine and Biology Society, Cerutti, S., Patton, J., Annual international conference of the IEEE Engineering in Medicine and Biology Society 37 2015.08.25-29 Milano, & EMBC 37 2015.08.25-29 Milano. (n.d.). 2015 37th annual international conference of the IEEE Engineering in Medicine and Biology Society (EMBC) 25 - 29 Aug. 2015, Milano / conference chairs Sergio Cerutti ... Jim Patton, ed. in chief for conference editorial board. [Google Scholar]
Garg, N. K., Tyagi, R. K., Singh, B., Sharma, G., Nirbhavane, P., Kushwah, V., Jain, S., & Katare, O. P. (2016). Nanostructured lipid carrier mediates effective delivery of methotrexate to induce apoptosis of rheumatoid arthritis via NF-κB and FOXO1. International Journal of Pharmaceutics, 499(1–2), 301–320.https://doi.org/10.1016/j.ijpharm.2015.12.061 [CrossRef] [PubMed] [Google Scholar]
Higaki, M., Ishihara, T., Izumo, N., Takatsu, M., & Mizushima, Y. (2005). Treatment of experimental arthritis with poly(D, L-lactic/glycolic acid) nanoparticles encapsulating betamethasone sodium phosphate. Annals of the Rheumatic Diseases, 64(8), 1132–1136.https://doi.org/10.1136/ard.2004.030759 [CrossRef] [PubMed] [Google Scholar]
Nagai, N., Tanino, T., & Ito, Y. (2016). Pharmacokinetic studies of gel system containing ibuprofen solid nanoparticles. Journal of Oleo Science, 65(12), 1045–1053.https://doi.org/10.5650/jos.ess16036 [CrossRef] [PubMed] [Google Scholar]
Chen, M., Daddy, K. A., Xiao, Y., Ping, Q., & Zong, L. (2017). Advanced nanomedicine for rheumatoid arthritis treatment: focus on active targeting. In Expert Opinion on Drug Delivery (Vol. 14, Issue 10, pp. 1141–1144). Taylor and Francis Ltd.https://doi.org/10.1080/17425247.2017.1372746 [CrossRef] [PubMed] [Google Scholar]
A. Verma, B. Kaur, S. Venugopal, P. Wadhwa, S. Sahu, P. Kaur, D. Kumar, A. Sharma, “Tetrazole: A privileged scaffold for the discovery of anticancer agents,” Chemical Biology & Drug Design, vol. 100, no. 3, 419-42, 2022.https://doi.org/10.1111/cbdd.14103 [CrossRef] [PubMed] [Google Scholar]
Ramasamy, T., Ruttala, H. B., Shanmugam, S., & Umadevi, S. K. (2013a). Eudragit-coated aceclofenac-loaded pectin microspheres in chronopharmacological treatment of rheumatoid arthritis. Drug Delivery, 20(2), 65–77.https://doi.org/10.3109/10717544.2012.762434 [CrossRef] [PubMed] [Google Scholar]
Sanka, K., Pragada, R. R., & Veerareddy, P. R. (2015). A pH-triggered delayed-release chronotherapeutic drug delivery system of aceclofenac for effective management of early morning symptoms of rheumatoid arthritis. Journal of Microencapsulation, 32(8), 794–803.https://doi.org/10.3109/02652048.2015.1081417 [CrossRef] [PubMed] [Google Scholar]
Vandana, K. R., Yalavarthi, P. R., Sundaresan, C. R., Sriramaneni, R. N., & Vadlamudi, H. C. (2014). Send Orders for Reprints to reprints@benthamscience.net In-Vitro Assessment and Pharmacodynamics of Nimesulide Incorporated Aloe veraTransemulgel. In Current Drug Discovery Technologies (Vol. 11). [Google Scholar]
Kramar, A., Turk, S., &Vrečer, F. (2003). Statistical optimisation of diclofenac sustained release pellets coated with polymethacrylic films. International Journal of Pharmaceutics, 256(1–2), 43–52.https://doi.org/10.1016/S0378-5173(03)00061-9 [CrossRef] [PubMed] [Google Scholar]
Waghule, T., Singhvi, G., Dubey, S. K., Pandey, M. M., Gupta, G., Singh, M., & Dua, K. (2019). Microneedles: A smart approach and increasing potential for transdermal drug delivery system. In Biomedicine and Pharmacotherapy (Vol. 109, pp. 1249–1258). Elsevier Masson SAS.https://doi.org/10.1016/j.biopha.2018.10.078 [CrossRef] [Google Scholar]
Yao, W., Tao, C., Zou, J., Zheng, H., Zhu, J., Zhu, Z., Zhu, J., Liu, L., Li, F., & Song, X. (2019). Flexible two-layer dissolving and safing microneedle transdermal of neurotoxin: A biocomfortable attempt to treat Rheumatoid Arthritis. International Journal of Pharmaceutics, 563, 91–100. https://doi.org/10.1016/j.ijpharm.2019.03.033 [CrossRef] [PubMed] [Google Scholar]
Poh, S., Chelvam, V., Kelderhouse, L. E., Ayala-López, W., Vaitilingam, B., Putt, K. S., & Low, P. S. (2017). Folate- conjugated liposomes target and deliver therapeutics to immune cells in a rat model of rheumatoid arthritis. Nanomedicine, 12(20), 2441–2451.https://doi.org/10.2217/nnm-2017-0166 [CrossRef] [PubMed] [Google Scholar]
Sultana, F., Neog, M. K., & Rasool, M. (2017). Withaferin-A, a steroidal lactone encapsulated mannose decorated liposomes ameliorates rheumatoid arthritis by intriguing the macrophage repolarization in adjuvant-induced arthritic rats. Colloids and surfaces. B, Biointerfaces, 155, 349–365.https://doi.org/10.1016/j.colsurfb.2017.04.046 [CrossRef] [PubMed] [Google Scholar]
Zeb, A., Qureshi, O. S., Yu, C. H., Akram, M., Kim, H. S., Kim, M. S., Kang, J. H., Majid, A., Chang, S. Y., Bae, O. N., & Kim, J. K. (2017). Enhanced anti-rheumatic activity of methotrexate-entrapped ultradeformable liposomal gel in adjuvant-induced arthritis rat model. International journal of pharmaceutics, 525(1), 92–100.https://doi.org/10.1016/j.ijpharm.2017.04.032 [CrossRef] [PubMed] [Google Scholar]
Hua, S., Dias, T. H., Pepperall, D. G., & Yang, Y. (2017). Topical Loperamide-Encapsulated Liposomal Gel Increases the Severity of Inflammation and Accelerates Disease Progression in the Adjuvant-Induced Model of Experimental Rheumatoid Arthritis. Frontiers in pharmacology, 8, 503.https://doi.org/10.3389/fphar.2017.00503 [CrossRef] [PubMed] [Google Scholar]
Neog, M. K., & Rasool, M. (2018). Targeted delivery of p-coumaric acid encapsulated mannosylated liposomes to the synovial macrophages inhibits osteoclast formation and bone resorption in the rheumatoid arthritis animal model. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur PharmazeutischeVerfahrenstechnike.V, 133, 162–175.https://doi.org/10.1016/j.ejpb.2018.10.010 [CrossRef] [Google Scholar]
Meka RR, Venkatesha SH, Acharya B, Moudgil KD. Peptide-targeted liposomal delivery of dexamethasone for arthritis therapy. Nanomedicine (Lond). 2019 Jun;14(11):1455-1469. doi: 10.2217/nnm-2018-0501. Epub 2019 Apr 2. PMID: 30938236; PMCID: PMC6613046. [CrossRef] [PubMed] [Google Scholar]
Hu, L., Luo, X., Zhou, S., Zhu, J., Xiao, M., Li, C., Zheng, H., Qiu, Q., Lai, C., Liu, X., Deng, Y., & Song, Y. (2019). Neutrophil-Mediated Delivery of Dexamethasone Palmitate-Loaded Liposomes Decorated with a Sialic Acid Conjugate for Rheumatoid Arthritis Treatment. Pharmaceutical research, 36(7), 97.https://doi.org/10.1007/s11095-019-2609-4 [CrossRef] [PubMed] [Google Scholar]
Nogueira E, Freitas J, Loureiro A et al. Neutral PEGylated liposomal formulation for efficient folate-mediated delivery of MCL1 siRNA to activated macrophages. Colloids Surf B. 155, 459–465 (2017). [CrossRef] [Google Scholar]
Xu, X. L., Li, W. S., Wang, X. J., Du, Y. L., Kang, X. Q., Hu, J. B., Li, S. J., Ying, X. Y., You, J., & Du, Y. Z. (2018). Endogenous sialic acid-engineered micelles: A multifunctional platform for on-demand methotrexate delivery and bone repair of rheumatoid arthritis. Nanoscale, 10(6), 2923–2935. https://doi.org/10.1039/c7nr08430g [CrossRef] [PubMed] [Google Scholar]
Wang, Y., Liu, Z., Li, T., Chen, L., Lyu, J., Li, C., Lin, Y., Hao, N., Zhou, M., & Zhong, Z. (2019). Enhanced Therapeutic Effect of RGD-Modified Polymeric Micelles Loaded With Low-Dose Methotrexate and Nimesulide on Rheumatoid Arthritis. Theranostics, 9(3), 708–720. https://doi.org/10.7150/thno.30418 [CrossRef] [PubMed] [Google Scholar]
Hao, F., Lee, R. J., Zhong, L., Dong, S., Yang, C., Teng, L., Meng, Q., Lu, J., Xie, J., & Teng, L. (2019). Hybrid micelles containing methotrexate-conjugated polymer and co-loaded with microRNA-124 for rheumatoid arthritis therapy. Theranostics, 9(18), 5282–5297.https://doi.org/10.7150/thno.32268 [CrossRef] [PubMed] [Google Scholar]
Wang, Q., Jiang, H., Li, Y., Chen, W., Li, H., Peng, K., Zhang, Z., & Sun, X. (2017). Targeting NF-kB signaling with polymeric hybrid micelles that co-deliver siRNA and dexamethasone for arthritis therapy. Biomaterials, 122, 10–22.https://doi.org/10.1016/j.biomaterials.2017.01.008 [CrossRef] [PubMed] [Google Scholar]
Ismail, T. A., Shehata, T. M., Mohamed, D. I., Elsewedy, H. S., & Soliman, W. E. (2021). Quality by Design for Development, Optimization and Characterization of Brucine Ethosomal Gel for Skin Cancer Delivery. Molecules (Basel, Switzerland), 26(11), 3454.https://doi.org/10.3390/molecules26113454 [CrossRef] [PubMed] [Google Scholar]
Mahla, S.K., Dhir, A., Gill, K.J., Cho, H.M., Lim, H.C. and Chauhan, B.S., 2018. Influence of EGR on the simultaneous reduction of NOx-smoke emissions trade-off under CNG-biodiesel dual fuel engine. Energy, 152, pp.303-312. [CrossRef] [Google Scholar]
Singh, A., Lin, Y., Ansari, K.R., Quraishi, M.A., Ebenso, E.E., Chen, S. and Liu, W., 2015. Electrochemical and surface studies of some Porphines as corrosion inhibitor for J55 steel in sweet corrosion environment. Applied Surface Science, 359, pp.331-339. [CrossRef] [Google Scholar]
Singh, A., Lin, Y., Liu, W., Yu, S., Pan, J., Ren, C. and Kuanhai, D., 2014. Plant derived cationic dye as an effective corrosion inhibitor for 7075 aluminum alloy in 3.5% NaCl solution. Journal of Industrial and Engineering Chemistry, 20(6), pp.4276-4285. [CrossRef] [Google Scholar]
Thakur, S., Riyaz, B., Patil, A., Kaur, A., Kapoor, B. and Mishra, V., 2018. Novel drug delivery systems for NSAIDs in management of rheumatoid arthritis: An overview. Biomedicine & Pharmacotherapy, 106, pp.1011-1023. [CrossRef] [Google Scholar]
Singh, A., 2012. Hydroxyapatite, a biomaterial: its chemical synthesis, characterization and study of biocompatibility prepared from shell of garden snail, Helix aspersa. Bulletin of Materials Science, 35(6), pp.1031-1038. [CrossRef] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.